Evaluation of a 24-gene signature for prognosis of metastatic events and prostate cancer-specific mortality.

Abstract

No abstract available.

Authors
  • Davicioni E
  • Erho N
  • Jenkins RB
  • Karnes RJ
  • Klein EA
  • Long Q
  • Moreno CS
  • Patil D
  • Pellegrini KL
  • Sanda MG
  • Santiago-Jiménez M
  • Takhar M
  • Yousefi K
PubMed ID
Appears In